Dr Hongchao Pan
Senior Research Fellow, CTSU
Hongchao Pan is a statistician and epidemiologist in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). He holds a PhD in astrophysics from University of Leicester and an MSc in epidemiology from London School of Hygiene & Tropical Medicine. Since joining CTSU in 1995, he has worked on number of large-scale randomised clinical trials (such as CAST, COMMIT/CCS2, ACST, ATLAS) and epidemiological studies.
His research interests include systemic treatments for early breast cancer, effect of obesity on breast cancer prognosis, and mortality from smoking. Dr Pan leads the meta-analysis of individual participant data of the breast cancer screening trials with mammography and the long-term follow-up of the British Doctors Study.
Smoking and risk of Parkinson's disease: 65 year follow-up of the British Doctors study
CLARKE R. et al, (2020), Neurology
Timing of procedural stroke and death in asymptomatic patients undergoing carotid endarterectomy: analysis of VACS, ACAS, ACST-1 and GALA RCTs
Poorthuis M. et al, (2019), British Journal of Surgery
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Pan H. et al, (2017), N Engl J Med, 377, 1836 - 1846